LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 156 filers reported holding LEGEND BIOTECH CORP in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,700,640 | -3.2% | 561,272 | -0.5% | 0.06% | +1.6% |
| Q2 2023 | $38,929,054 | -23.1% | 563,944 | -46.3% | 0.06% | -24.1% |
| Q1 2023 | $50,651,397 | -4.8% | 1,050,423 | -1.4% | 0.08% | -11.7% |
| Q4 2022 | $53,190,908 | -7.3% | 1,065,523 | -24.3% | 0.09% | -6.9% |
| Q3 2022 | $57,396,000 | -38.8% | 1,406,767 | -17.6% | 0.10% | -36.5% |
| Q2 2022 | $93,858,000 | +44.9% | 1,706,516 | -4.2% | 0.16% | +87.1% |
| Q1 2022 | $64,761,000 | -27.2% | 1,782,085 | -6.7% | 0.08% | -19.0% |
| Q4 2021 | $89,001,000 | +58.7% | 1,909,485 | +72.2% | 0.10% | +54.4% |
| Q3 2021 | $56,076,000 | +36.6% | 1,109,102 | +10.9% | 0.07% | +38.8% |
| Q2 2021 | $41,060,000 | +67.4% | 1,000,247 | +18.4% | 0.05% | +58.1% |
| Q1 2021 | $24,523,000 | – | 845,048 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |